Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Biliary Atresia

Biliary Atresia

Part of Bile Duct Diseases

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Biliary Atresia

5 trials tracked for Biliary Atresia.

5Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Phase 1 1 Other / NA 1
  1. Phase 2 N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy Completed
  2. Phase 2 Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia Completed
  3. Phase 2 Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai Completed
  4. Phase 1 Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Completed
  5. N/A A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
The bile acid-gut microbiota-vitamin D axis may influence pathogenesis of biliary atresia
Gastroenterology Sys. Review
The bile acid-gut microbiota-vitamin D axis may influence pathogenesis of biliary atresia Bile acid-gut microbiota-vitamin D axis may affect biliary atresia
This systematic review examines the roles of bile acid metabolism, gut microbiota composition, and vitamin D levels in children with biliary…
A new review suggests a link between bile acids, gut bacteria, and vitamin D in biliary atresia, offering potential new treatment targets.
Frontiers Jun 23, 2026
Retrospective analysis of 326 infants with infantile cholestasis reveals etiological spectrum
Pediatrics Cohort
Retrospective analysis of 326 infants with infantile cholestasis reveals etiological spectrum Simple Blood Marker Could Save Babies from Surgery Delays
This retrospective cohort study evaluated 326 infants diagnosed with infantile cholestasis at the Children's Hospital Affiliated to Shandong…
A new blood test might help doctors find the right cause of baby liver disease faster.
Frontiers Apr 22, 2026
Maternal infections, diabetes, and preterm birth associated with neonatal biliary atresia risk
Diabetes & Endocrinology Meta-analysis
Maternal infections, diabetes, and preterm birth associated with neonatal biliary atresia risk A Mother’s Health May Shape Her Newborn’s Rare Liver Disease Risk
A meta-analysis of 10 retrospective studies in neonates found maternal urogenital infection (OR 1.21), diabetes (OR 1.55), preterm birth (OR…
A mother's diabetes or infection during pregnancy is linked to a higher risk of a serious infant liver condition, offering new clues for ear…
Frontiers Apr 12, 2026